Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection approved in Europe for the treatment of knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing osteoarthritis, which affects around one in four adults in Ireland aged over 601 (over 400,000 people)2 and current treatments are not long lasting or involve invasive knee replacement surgery. Despite a large suffering population, there has been very little innovation in the range of osteoarthritis treatments on offer to meaningfully help patients – until now.

Innovative Ways to Manage Patellofemoral Pain Syndrome: From Exercise Selection to Everyday Movement Strategies
Patellofemoral pain syndrome (PFPS), known as ‘runner’s knee,’ causes pain around the kneecap, affecting daily activities like walking and sitting. This condition often impacts young women and arises from muscle weakness, poor kneecap alignment, and overuse. Effective management includes targeted exercises—such as quadriceps strengthening and glute bridges—and lifestyle adjustments like proper sitting and sleeping postures. Early diagnosis and personalized treatment plans are essential, as some physical tests have limited sensitivity. While conservative treatments often relieve symptoms, persistent cases may require advanced interventions, including surgery. Utilizing evidence-based strategies and resources like NHS guides can help reduce PFPS discomfort and improve knee function, enabling a return to active, pain-free movement.
